Germ that causes stomach ulcers protective for oesophageal cancer

April 30, 2010, Queensland Institute of Medical Research

(PhysOrg.com) -- An Australian study has found that a bacterium that causes ulcers and cancers of the stomach appears to dramatically reduce the risk of one particular type of oesophageal cancer.

Dr David Whiteman from the Queensland Institute of Medical Research (QIMR) said might be considered an unusual candidate for protection against gastro-intestinal disease. “We know that H. pylori infection causes gastritis, stomach ulcers and cancers of the stomach, so it might seem odd to propose that this could also have benefits.”

“Previous research has suggested that H. pylori may actually reduce the risk of oesophageal cancer, but little was known about how it did so.”

The study analysed blood samples from more than 2,000 Australian participants (800 with oesophageal cancer and 1,400 without) to determine if they had H. pylori in their blood. Researchers also determined whether participants carried common genes that are thought to determine a person’s response to H. pylori.

“We found that patients with one particular type of oesophageal cancer - adenocarcinomas - were less than half as likely to be infected with H. pylori than people without cancer, whereas patients with squamous cell cancers had a similar rate of infection as people without . In other words, H. pylori infection appeared to reduce the risk of adenocarcinoma by more than 50%.”

The investigators had expected to find that the protective effects of H. pylori infection might be restricted to those people carrying certain genes that regulate inflammation, but they found that the reduction in risk was the same regardless of which genes a person had.

“We now need to understand how this reduces the risk of of the oesophagus. We have some theories.”

Infection with H. pylori is common worldwide, although the prevalence of infection has declined in Western countries due to smaller family sizes and improved hygiene.

“About 50% of people worldwide have H. pylori living in their stomach. In most, the infection does not cause any symptoms, but in about 10% of people, it causes inflammation of the stomach,” said Dr Whiteman.


The study is published in the Gastroenterology, and is available online.

Related Stories

Recommended for you

3-D mammography detected 34% more breast cancers in screening

October 15, 2018
In traditional mammography screening, all breast tissue is captured in a single image. Breast tomosynthesis, on the other hand, is three-dimensional and works according to the same principle as what is known as tomography. ...

More clues revealed in link between normal breast changes and invasive breast cancer

October 15, 2018
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process—changes in mammary glands to accommodate breastfeeding—uses a molecular process believed ...

Cancer stem cells use 'normal' genes in abnormal ways

October 12, 2018
CDK1 is a "normal" protein—its presence drives cells through the cycle of replication. And MHC Class I molecules are "normal" as well—they present bits of proteins on the surfaces of cells for examination by the immune ...

Obesity linked to increased risk of early-onset colorectal cancer

October 12, 2018
Women who are overweight or obese have up to twice the risk of developing colorectal cancer before age 50 as women who have what is considered a normal body mass index (BMI), according to new research led by Washington University ...

Potential therapy for treatment-resistant hypothyroidism proves effective in lab study

October 12, 2018
A new "metal-coordinated" drug-delivery technology potentially could be used to supplement the standard therapy for hypothyroidism, which affects nearly 10 million Americans, and many more patients worldwide, according to ...

Researchers find a 'critical need' for whole genome sequencing of young cancer patients

October 12, 2018
St. Jude Children's Research Hospital has re-defined the gold standard for diagnostic testing of childhood cancer patients in the precision-medicine era and has implemented the testing for new cancer patients. The findings ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.